Vireo Growth (VREOF) Assets Average (2021 - 2026)

Vireo Growth (VREOF) reported Assets Average of $873.0 million for Q1 2026, up 214.08% on a YoY basis from $278.0 million in Q1 2025, and up 16.7% sequentially from $748.1 million in Q4 2025.

Vireo Growth (VREOF) Assets Average (2021 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 6 years of Assets Average data on file, last reported at $873.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Assets Average rose 214.08% year-over-year to $873.0 million; the trailing twelve-month figure through Mar 2026 stood at $873.0 million (up 214.08% YoY), and the FY2025 full-year result was $548.0 million, up 137.18% from the prior year.
  • Assets Average advanced to $873.0 million in Q1 2026, from $748.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $873.0 million in Q1 2026 to a low of $158.9 million in Q1 2023.
  • A 5-year average of $304.7 million and a median of $187.1 million in 2024 frame the typical range for Assets Average.
  • Across the five-year window, Assets Average retreated 3.02% in 2023 and soared 244.42% in 2025, its largest moves.
  • Tracing VREOF's Assets Average over 5 years: stood at $166.2 million in 2022, then advanced by 6.75% to $177.5 million in 2023, then jumped by 33.19% to $236.4 million in 2024, then jumped by 216.48% to $748.1 million in 2025, then rose by 16.7% to $873.0 million in 2026.
  • Business Quant data shows VREOF's Assets Average at $873.0 million in Q1 2026, $748.1 million in Q4 2025, and $669.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.72 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.39 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.32 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 99.52 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 7.30 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 68.63 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 37.01 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.77 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.29 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 873.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 873.00 Mn
Dec 31, 2025 748.06 Mn
Sep 30, 2025 669.13 Mn
Jun 30, 2025 468.19 Mn
Mar 31, 2025 277.95 Mn
Dec 31, 2024 236.37 Mn
Sep 30, 2024 194.27 Mn
Jun 30, 2024 192.78 Mn
Mar 31, 2024 187.07 Mn
Dec 31, 2023 177.47 Mn
Sep 30, 2023 168.81 Mn
Jun 30, 2023 162.29 Mn
Mar 31, 2023 158.89 Mn
Dec 31, 2022 166.24 Mn
Sep 30, 2022 171.07 Mn
Jun 30, 2022 164.78 Mn
Mar 31, 2022 163.85 Mn
Dec 31, 2021 165.57 Mn
Sep 30, 2021 138.42 Mn
Jun 30, 2021 118.06 Mn